StockData
Tonix Pharmaceuticals Holding Corp. logo

Tonix Pharmaceuticals Holding Corp. (TNXP) stock

TNXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3083% below fair value
$2.94+0.06 (+2.08%)

Close on Nov 17, 2026Market cap $50.42MP/E –Yield –

Earnings

Tonix Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 12, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$17.20M
EPS, Q3 FY2026
-$2.89
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Tonix Pharmaceuticals's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 12, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 9, 2026before the open$17.20M–-$2.89Release
Q2 FY2026ended Jun 30, 2026Aug 10, 2026before the open$13.54M–-$2.44Release
Q1 FY2026ended Mar 31, 2026May 1, 2026after the close–––Filing
Q4 FY2025ended Dec 31, 2025Mar 13, 2026before the open$5.40M+107.7%-$3.98Release
Q3 FY2025ended Sep 30, 2025Oct 27, 2025before the open–––Filing
Q2 FY2025ended Jun 30, 2025Jul 25, 2025after the close–––Filing
Q1 FY2025ended Mar 31, 2025Apr 25, 2025after the close–––Filing
Q4 FY2024ended Dec 31, 2024Mar 18, 2025after the close$2.60M-31.6%-$9.77Release
Q3 FY2024ended Sep 30, 2024Oct 28, 2024after the close–––Filing
Q2 FY2024ended Jun 30, 2024Aug 9, 2024after the close–––Filing
Q1 FY2024ended Mar 31, 2024May 13, 2024after the close$2.50M–-$0.18Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Tonix Pharmaceuticals has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Tonix Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Tonix Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. News
  3. News
  4. Results
  5. Update
  6. Update
  7. Update
  8. Update
  9. Update
  10. Update
  11. Update
  12. Results
  13. Update
  14. Update
  15. Update

See a number that looks wrong?